Don’t middle your MIDs: regression to the mean shrinks estimates of minimally important differences

Statistical Power Analysis for the Behavioral Sciences

Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,588 · see citing works

Statistical power analysis for the behavioral sciences

Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,406 · see citing works

Statistical Power Analysis for the Behavioral Sciences (2nd ed.).

Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,385 · see citing works

Measurement of health status

Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982 · see citing works

Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation

Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700 · see citing works

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

Revicki, D. A., Hays, R. D., Cella, D. F., & Sloan, J. A. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.012 · Cited by 2,384 · see citing works

Regression Towards Mediocrity in Hereditary Stature.

Galton, F. (1886) · The Journal of the Anthropological Institute of Great Britain and Ireland · doi:10.2307/2841583 · Cited by 1,474 · see citing works

Autobiographical Memory and the Validity of Retrospective Reports

Schwarz, N., & Sudman, S. (1994) · Springer eBooks · doi:10.1007/978-1-4612-2624-6 · Cited by 491 · see citing works

Interpreting patient-reported outcome results: US FDA guidance and emerging methods

McLeod, L., Coon, C. D., Martin, S. A., Fehnel, S. E., & Hays, R. D. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.12 · Cited by 318 · see citing works

Approaches and Recommendations for Estimating Minimally Important Differences for Health-Related Quality of Life Measures

Hays, R. D., Farivar, S. S., & Liu, H. (2005) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200050663 · Cited by 250 · see citing works

Half standard deviation estimate of the minimally important difference in HRQOL scores?

Farivar, S. S., Liu, H., & Hays, R. D. (2004) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.4.5.515 · Cited by 182 · see citing works

Hi! How are you? Response shift, implicit theories and differing epistemologies

Norman, G. R. (2003) · Quality of Life Research · doi:10.1023/a:1023211129926 · Cited by 172 · see citing works

Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials

Sun~er, I. J., Kokame, G. T., Yu, E., Ward, J., Dolan, C., & Bressler, N. M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3225 · Cited by 170 · see citing works

Linking scores from multiple health outcome instruments

Dorans, N. J. (2007) · Quality of Life Research · doi:10.1007/s11136-006-9155-3 · Cited by 119 · see citing works

Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma

Kvam, A. K., Wislöff, F., & Fayers, P. M. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-79 · Cited by 72 · see citing works

Should Linking Replace Regression When Mapping from Profile-Based Measures to Preference-Based Measures?

Fayers, P. M., & Hays, R. D. (2014) · Value in Health · doi:10.1016/j.jval.2013.12.002 · Cited by 64 · see citing works

Cannabis-based medicines for chronic neuropathic pain in adults

Mücke, M., Phillips, T., Radbruch, L., Petzke, F. W., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012182.pub2 · Cited by 606 · see citing works

Estimating the minimum important change in the 15D scores

Alanne, S., Roine, R. P., Räsänen, P., Vainiola, T., & Sintonen, H. (2015) · Quality of Life Research · doi:10.1007/s11136-014-0787-4 · Cited by 231 · see citing works

Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome – A systematic review and meta-analysis of randomized controlled trials

Bernardy, K., Klose, P., Welsch, P., & Häuser, W. (2018) · European Journal of Pain · doi:10.1002/ejp.1121 · Cited by 217 · see citing works

Adaptive behavior in autism: Minimal clinically important differences on the Vineland‐II

Chatham, C., Taylor, K. I., Charman, T., D’ardhuy, X. L., Eule, E., Fedele, A., Hardan, A. Y., Loth, E., Murtagh, L., Rubido, M. D. V., et al. (2017) · Autism Research · doi:10.1002/aur.1874 · Cited by 170 · see citing works

Systematic review and meta‐analysis of cannabinoids in palliative medicine

Mücke, M., Weier, M., Carter, C., Copeland, J., Degenhardt, L. J., Cuhls, H., Radbruch, L., Häuser, W., & Conrad, R. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12273 · Cited by 157 · see citing works

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia

Welsch, P., Üçeyler, N., Klose, P., Walitt, B. T., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010292.pub2 · Cited by 152 · see citing works

Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis)

Fitzcharles, M., Baerwald, C., Ablin, J. N., & Häuser, W. (2016) · Der Schmerz · doi:10.1007/s00482-015-0084-3 · Cited by 150 · see citing works

Moving from significance to real-world meaning: methods for interpreting change in clinical outcome assessment scores

Coon, C. D., & Cook, K. F. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1616-3 · Cited by 129 · see citing works

Selective serotonin reuptake inhibitors for fibromyalgia syndrome

Walitt, B. T., Urrútia, G., Nishishinya, M. B., Cantrell, S. E., & Häuser, W. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011735 · Cited by 108 · see citing works

Efficacy, acceptability and safety of guided imagery/hypnosis in fibromyalgia: a systematic review and meta-analysis of randomized controlled trials

Zech, N., Hansen, E., Bernardy, K., & Häuser, W. (2017) · European Journal of Pain · doi:10.1002/ejp.933 · Cited by 111 · see citing works

Long-Term Opioid Use in Non-Cancer Pain

Häuser, W., Bock, F., Engeser, P., Tölle, T. R., Willweber-Strumpf, A., & Petzke, F. W. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0732 · Cited by 100 · see citing works

Efficacy, tolerability and safety of cannabis-based medicines for cancer pain

Häuser, W., Welsch, P., Klose, P., Radbruch, L., & Fitzcharles, M. (2019) · Der Schmerz · doi:10.1007/s00482-019-0373-3 · Cited by 94 · see citing works

Opioids for chronic non‐cancer neuropathic pain. An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks duration

Sommer, C., Klose, P., Welsch, P., Petzke, F. W., & Häuser, W. (2019) · European Journal of Pain · doi:10.1002/ejp.1494 · Cited by 83 · see citing works

Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults

Derry, S., Wiffen, P. J., Häuser, W., Mücke, M., Tölle, T. R., Bell, R. F., & Moore, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012332.pub2 · Cited by 82 · see citing works

Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden bei neuropathischen Schmerzsyndromen: Eine systematische Übersichtsarbeit von randomisierten, kontrollierten Studien

Petzke, F., Enax-Krumova, E. K., & Häuser, W. (2016) · Der Schmerz · doi:10.1007/s00482-015-0089-y · Cited by 80 · see citing works

Later retirement, job strain, and health: Evidence from the new State Pension age in the United Kingdom

Carrino, L., Glaser, K., & Avendaño, M. (2020) · Health Economics · doi:10.1002/hec.4025 · Cited by 78 · see citing works

Knowledge Sharing and Life Satisfaction: The Roles of Colleague Relationships and Gender

Jiang, Z., & Hu, X. (2015) · Social Indicators Research · doi:10.1007/s11205-015-0886-9 · Cited by 78 · see citing works

Opioide bei chronischem neuropathischem Schmerz

Sommer, C., Welsch, P., Klose, P., Schaefert, R., Petzke, F. W., & Häuser, W. (2014) · Der Schmerz · doi:10.1007/s00482-014-1455-x · Cited by 76 · see citing works

Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog)

Bell, M. L., Dhillon, H. M., Bray, V., & Vardy, J. L. (2018) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-018-0071-4 · Cited by 66 · see citing works

Opioids for chronic low back pain: An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks of double‐blind duration

Petzke, F. W., Klose, P., Welsch, P., Sommer, C., & Häuser, W. (2019) · European Journal of Pain · doi:10.1002/ejp.1519 · Cited by 65 · see citing works

Interpretability of the PedsQL Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in Pediatric Patients With Functional and Organic Gastrointestinal Diseases

Varni, J. W., Bendo, C. B., Shulman, R. J., Self, M. M., Nurko, S., Franciosi, J. P., Saps, M., Saeed, S. A., Zacur, G. M., Dark, C. V., et al. (2015) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsv005 · Cited by 65 · see citing works

Cannabis-based medicines and medical cannabis for adults with cancer pain

Häuser, W., Welsch, P., Radbruch, L., Fisher, E., Bell, R. F., & Moore, A. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014915.pub2 · Cited by 83 · see citing works

Opioide bei chronischem Arthroseschmerz

Schaefert, R., Welsch, P., Klose, P., Sommer, C., Petzke, F. W., & Häuser, W. (2014) · Der Schmerz · doi:10.1007/s00482-014-1451-1 · Cited by 57 · see citing works

Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis

Witt, S., Krauss, E., Barbero, M. A. N., Müller, V., Bonniaud, P., Vancheri, C., Wells, A. U., Vašáková, M., Pesci, A., Klepetko, W., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1010-5 · Cited by 54 · see citing works

Spiritual well-being and spiritual distress predict adjustment in adolescent and young adult cancer survivors

Park, C. L., & Cho, D. (2016) · Psycho-Oncology · doi:10.1002/pon.4145 · Cited by 53 · see citing works

Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial results

Mehta, L. R., McNeill, M., Hobart, J. C., Wyrwich, K. W., Poon, J. L., Auguste, P., Zhong, J., & Elkins, J. S. (2015) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217315596993 · Cited by 51 · see citing works

Efficacy, acceptability and safety of internet-delivered psychological therapies for fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials

Bernardy, K., Klose, P., Welsch, P., & Häuser, W. (2019) · European Journal of Pain · doi:10.1002/ejp.1284 · Cited by 50 · see citing works

Examining the Minimal Important Difference of Patient-reported Outcome Measures for Individuals with Knee Osteoarthritis: A Model Using the Knee Injury and Osteoarthritis Outcome Score

Mills, K. A. G., Naylor, J., Eyles, J. P., Roos, E. M., & Hunter, D. J. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.150398 · Cited by 48 · see citing works

Antipsychotics for fibromyalgia in adults

Walitt, B. T., Klose, P., Üçeyler, N., Phillips, T., & Häuser, W. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011804.pub2 · Cited by 48 · see citing works

Opioids for chronic osteoarthritis pain: An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks double‐blind duration

Welsch, P., Petzke, F. W., Klose, P., & Häuser, W. (2019) · European Journal of Pain · doi:10.1002/ejp.1522 · Cited by 46 · see citing works

Best (but oft-forgotten) practices: expressing and interpreting associations and effect sizes in clinical outcome assessments

McLeod, L., Cappelleri, J. C., & Hays, R. D. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.120378 · Cited by 43 · see citing works

Is Physiotherapy Self‐Referral with Telephone Triage Viable, Cost‐effective and Beneficial to Musculoskeletal Outpatients in a Primary Care Setting?

Mallett, R., Bakker, E., & Burton, M. (2014) · Musculoskeletal Care · doi:10.1002/msc.1075 · Cited by 41 · see citing works

Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults

Derry, S., Wiffen, P. J., Häuser, W., Mücke, M., Tölle, T. R., Bell, R. F., & Moore, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012332 · Cited by 60 · see citing works

Likely change indexes improve estimates of individual change on patient-reported outcomes

Peipert, J. D., Hays, R. D., & Cella, D. F. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03200-4 · Cited by 39 · see citing works

Mirtazapine for fibromyalgia in adults

Welsch, P., Bernardy, K., Derry, S., Moore, A., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012708.pub2 · Cited by 38 · see citing works

Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease

Finkelstein, F. O., van Nooten, F. E., Wiklund, I. E., Trundell, D., & Cella, D. F. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-0933-8 · Cited by 37 · see citing works

Iron-containing cookware for the reduction of iron deficiency anemia among children and females of reproductive age in low- and middle-income countries: A systematic review

Alves, C., Saleh, A. A., & Alaofè, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221094 · Cited by 37 · see citing works

Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden in der Gastroenterologie

Volz, M. S., Siegmund, B., & Häuser, W. (2016) · Der Schmerz · doi:10.1007/s00482-015-0087-0 · Cited by 33 · see citing works

How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold

Griffiths, P., Sims, J., Williams, A., Williamson, N., Cella, D. F., Brohan, E., & Cocks, K. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03286-w · Cited by 32 · see citing works

Opioide bei chronischem Kreuzschmerz

Petzke, F. W., Welsch, P., Klose, P., Schaefert, R., Sommer, C., & Häuser, W. (2014) · Der Schmerz · doi:10.1007/s00482-014-1449-8 · Cited by 31 · see citing works

The perspective of prostate cancer patients and patients' partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples

Hamilton, L. D., Dam, D. V., & Wassersug, R. J. (2015) · Psycho-Oncology · doi:10.1002/pon.3930 · Cited by 27 · see citing works

Does Future Diabetes Risk Impair Current Quality of Life? A Cross-Sectional Study of Health-Related Quality of Life in Relation to the Finnish Diabetes Risk Score (FINDRISC)

Väätäinen, S. T., Cederberg, H., Roine, R. P., Keinanen-Kiukaanniemi, S. M., Saramies, J., Uusitalo, H. M. T., Tuomilehto, J., & Martikainen, J. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147898 · Cited by 26 · see citing works

Interpretation and use of the 5-level EQ-5D response labels varied with survey language among Asians in Singapore

Luo, N., Wang, Y., How, C. H., Tay, E. G., Thumboo, J., & Herdman, M. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.04.011 · Cited by 25 · see citing works

The challenges inherent with anchor-based approaches to the interpretation of important change in clinical outcome assessments

Wyrwich, K. W., & Norman, G. R. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03297-7 · Cited by 23 · see citing works

Psychometric Validation of the Autism Impact Measure (AIM)

Houghton, R., Monz, B. U., Law, K., Loss, G. J., Scouiller, S. L., de Vries, F., & Willgoss, T. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04011-2 · Cited by 23 · see citing works

Perceived discrimination amongst young people in socio‐economically disadvantaged communities: Parental support and community identity buffer (some) negative impacts of stigma

Bradshaw, D., Jay, S., McNamara, N., Stevenson, C., & Muldoon, O. T. (2015) · British Journal of Developmental Psychology · doi:10.1111/bjdp.12120 · Cited by 22 · see citing works

Mirtazapine for fibromyalgia in adults

Welsch, P., Bernardy, K., Derry, S., Moore, R. A., & Häuser, W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012708 · Cited by 20 · see citing works

Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis

Simpson, E. L., de Bruin-Weller, M. S., Bansal, A., Chen, Z., Nelson, L. M., Whalley, D., Prescilla, R. P., Guillemin, I., & Delevry, D. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00543-7 · Cited by 19 · see citing works

Cannabinoids for chronic neuropathic pain

Mücke, M., Phillips, T., Radbruch, L., Petzke, F. W., & Häuser, W. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012182 · Cited by 18 · see citing works

Investigating the minimal important difference in ambulation in multiple sclerosis: A disconnect between performance-based and patient-reported outcomes?

Schwartz, C. E., Ayandeh, A., & Motl, R. W. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.10.021 · Cited by 17 · see citing works

Methodenreport der aktualisierten Leitlinie „Langzeitanwendung von Opioiden bei nicht-tumorbedingten Schmerzen – LONTS“

Häuser, W., Klose, P., Welsch, P., Petzke, F. W., Nothacker, M., & Kopp, I. (2014) · Der Schmerz · doi:10.1007/s00482-014-1462-y · Cited by 16 · see citing works

Development and evaluation of the Acromegaly Symptom Diary

Martin, S. A., Bender, R. H., Krasner, A. S., Marmon, T., Monahan, M., & Nelson, L. M. (2023) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-023-00541-7 · Cited by 16 · see citing works

Is religious and existential well-being important in quality of life in Hong Kong Chinese?

Chan, K. (2018) · The Social Science Journal · doi:10.1016/j.soscij.2018.02.012 · Cited by 15 · see citing works

Cannabis-based medicines and medical cannabis for adults with cancer pain

Häuser, W., Welsch, P., Radbruch, L., Fisher, E., Bell, R. F., & Moore, A. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014915 · Cited by 14 · see citing works

The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Guidance for Use in Research and Clinical Practice

Webster, K., Peipert, J. D., Lent, L., Bredle, J. M., & Cella, D. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-84702-9_6 · Cited by 14 · see citing works

Mapping the disease-specific LupusQoL to the SF-6D

Meacock, R., Harrison, M. J., McElhone, K., Abbott, J., Haque, S., Bruce, I. N., & Teh, L. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0892-4 · Cited by 14 · see citing works

Minimal clinically important difference of modified dynamic gait index in people with neurological disorders

Corrini, C., Torchio, A., Anastasi, D., Parelli, R., Meotti, M., Spedicato, A., Groppo, E., d’Arma, A., Grosso, C., Montesano, A., et al. (2021) · Gait & Posture · doi:10.1016/j.gaitpost.2021.08.024 · Cited by 13 · see citing works

Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges.

Shields, A. L., Hao, Y., Krohe, M., Yaworsky, A., Mazar, I., Foley, C., Mehmed, F., & GLOBE, D. R. (2016) · Europe PMC (PubMed Central) · Cited by 13 · see citing works

When Life Happens: Investigating Short and Long-Term Effects of Life Stressors on Life Satisfaction in a Large Sample of Norwegian Mothers

Dyrdal, G. M., Røysamb, E., Nes, R. B., & Vittersø, J. (2018) · Journal of Happiness Studies · doi:10.1007/s10902-018-0024-x · Cited by 10 · see citing works

Erratum zu: Opioide bei chronischem Kreuzschmerz: Systematische Übersicht und Metaanalyse der Wirksamkeit, Verträglichkeit und Sicherheit in randomisierten, placebokontrollierten Studien über mindestens 4 Wochen

Petzke, F. W., Welsch, P., Klose, P., Schaefert, R., Sommer, C., & Häuser, W. (2015) · Der Schmerz · Cited by 10 · see citing works

The minimally clinically important difference in the 2-minute walk test for people in the subacute phase after a stroke

Bowman, T., Mattos, F. G. M., Longo, C. A., Bocini, S., Gennuso, M., Marazzini, F., Materazzi, F. G., Pelosin, E., Putzolu, M., Salvalaggio, S., et al. (2024) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2024.2417643 · Cited by 9 · see citing works

Cannabis-based medicines for chronic neuropathic pain in adults

Ateş, G., Welsch, P., Klose, P., Phillips, T., Lambers, B., Häuser, W., & Radbruch, L. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012182.pub3 · Cited by 11 · see citing works

Patient-reported questionnaires in MS rehabilitation: responsiveness and minimal important difference of the multiple sclerosis questionnaire for physiotherapists (MSQPT)

van der Maas, N. A. (2017) · BMC Neurology · doi:10.1186/s12883-017-0834-1 · Cited by 9 · see citing works

Leitlinienreport der zweiten Aktualisierung der S3-Leitlinie „Langzeitanwendung von Opioiden bei nicht-tumorbedingten Schmerzen – LONTS“

Häuser, W., Klose, P., Welsch, P., Petzke, F. W., & Nothacker, M. (2020) · Der Schmerz · doi:10.1007/s00482-020-00471-z · Cited by 9 · see citing works

Clinical cut-offs for hip- and knee arthroplasty outcome - minimal clinically important improvement (MCII) and patient acceptable symptom state (PASS) of patient-reported outcome measures (PROM)

Paulsen, A., Djuv, A., & Dalen, I. (2025) · Quality of Life Research · doi:10.1007/s11136-025-03896-0 · Cited by 8 · see citing works

Clinical Trial Patient-reported Outcomes Data: Going Beyond the Label in Oncology

Hao, Y., Krohe, M., Yaworsky, A., Shields, A. L., Mazar, I., Foley, C., & GLOBE, D. R. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.010 · Cited by 8 · see citing works

Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data

Morga, A., Zimmermann, L., Valluri, U., Siddiqui, E. J., McLeod, L., & Bender, R. H. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02849-2 · Cited by 7 · see citing works

The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D?

Whitehurst, D. G. T., Brazier, J. E., Viney, R. C., & Mulhern, B. J. (2020) · PharmacoEconomics · doi:10.1007/s40273-020-00957-9 · Cited by 7 · see citing works

Erratum zu: Verträglichkeit und Sicherheit von Cannabinoiden bei neuropathischen Schmerzsyndromen. Eine systematische Übersichtsarbeit von randomisierten, kontrollierten Studien

Petzke, F. W., Enax‐Krumova, E., & Häuser, W. (2017) · Der Schmerz · doi:10.1007/s00482-017-0242-x · Cited by 7 · see citing works

Psychometric evaluation of the DAILY EATS questionnaire in individuals living with obesity

Fastenau, J. M., Rozjabek, H., Qin, S., McLeod, L., Nelson, L. M., Ma, J., & Harris, N. (2020) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-020-00259-w · Cited by 6 · see citing works

Comparison of anchor-based methods for estimating thresholds of meaningful within-patient change using simulated PROMIS PF 20a data under various joint distribution characteristic conditions

Qin, S., Nelson, L. M., Williams, N., Williams, V. S. L., Bender, R. H., & McLeod, L. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03285-x · Cited by 6 · see citing works

An extension minimal important difference credibility item addressing construct proximity is a reliable alternative to the correlation item

Wang, Y., Devji, T., Carrasco‐Labra, A., Qasim, A., Hao, Q., Kum, E., Devasenapathy, N., King, M. T., Terluin, B., Terwee, C. B., et al. (2023) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2023.03.001 · Cited by 5 · see citing works

The Autism Impact Measure (AIM): Meaningful Change Thresholds and Core Symptom Changes Over One Year from an Online Survey in the U.S.

Silkey, M., Durán-Pacheco, G., Johnson, M., Liu, C., Clinch, S. P., Law, K., & Loss, G. J. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05635-7 · Cited by 5 · see citing works

Meaningful changes in physical function and pain in patients with knee osteoarthritis

Tang, X., Lai, J., Kang, S. K., & Peipert, J. D. (2025) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-025-00941-x · Cited by 3 · see citing works

Impaired health-related quality of life due to elevated risk of developing diabetes: A cross-sectional study in Indonesia

Rokhman, M. R., Arifin, B., Broggi, B., Verhaar, A.-F. S., Zulkarnain, Z., Satibi, S., Perwitasari, D. A., Boersma, C., Cao, Q., Postma, M. J., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295934 · Cited by 3 · see citing works

Determining the minimally clinically important difference for the pediatric liver transplant quality of life questionnaire

Kortbeek, S., Johara, F. T., Kwan, K., John, T., & Ng, V. L. (2024) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.12256 · Cited by 2 · see citing works

A weighted predictive modeling method for estimating thresholds of meaningful within-individual change for patient-reported outcomes

Zhao, C.-Y., Yan, M.-Q., Xu, X., & Ou, C. (2025) · Quality of Life Research · doi:10.1007/s11136-025-03924-z · Cited by 2 · see citing works

Patient-Reported Outcome Measures: Development and Psychometric Evaluation

McLeod, L., Fehnel, S. E., & Cappelleri, J. C. (2018) · ICSA book series in statistics · doi:10.1007/978-981-10-7829-3_13 · Cited by 2 · see citing works

Clinically meaningful change threshold in health‐related quality of life among patients aged 6 months to 5 years with atopic dermatitis and their caregiver(s)/family

Paller, A. S., Marrón, S. E., Whalley, D., Nelson, L. M., Qin, S., Chao, J., Bansal, A., Chuang, C., & Wang, Z. (2023) · JEADV Clinical Practice · doi:10.1002/jvc2.290 · Cited by 1 · see citing works

Interpretation of clinically meaningful change in cancer palliative care patients’ quality of life: minimally important difference for EORTC QLQ-C15-PAL

Miyazaki, K., Suzukamo, Y., Ikenaga, M., Ohsumi, S., Saito, M. K., Satomi, E., Shimozuma, K., & Nakayama, T. (2025) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-025-00858-5 · Cited by 1 · see citing works

Patient-Reported Questionnaires in Multiple Sclerosis Rehabilitation: Responsiveness and Minimal Important Difference of the French Version of the Multiple Sclerosis Questionnaire for Physiotherapists

van der Maas, N. A., & Ferchichi, S. (2020) · Physiotherapy Canada · doi:10.3138/ptc-2019-0096 · Cited by 1 · see citing works

Opioids in chronic neuropathic pain

Sommer, C., Welsch, P., Klose, P., Petzke, F. W., Häuser, W., & Saarbrücken, K. (2015)

Methodology report on the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain

Medizin, I., & Saarbrücken, K. (2015)

Comparison of Anchor- and Distribution-Based Methods for Estimating Thresholds of Meaningful Within-Patient Change Using Simulated PROMIS PF 20a Data Under Various Joint Distribution Characteristic ConditionsPreprint

Qin, S., Nelson, L. M., Williams, N., Williams, V. S. L., Bender, R. H., & McLeod, L. (2021) · Research Square · doi:10.21203/rs.3.rs-381557/v1

Fray Luis de León y la Universidad de Salamanca, el "mundanal ruïdo"

Lera, J. S. J. (1997) · Insula-revista De Letras Y Ciencias Humanas

References

Fayers, P. M., & Machin, D. (2015) · Wiley eBooks · doi:10.1002/9781118758991.refs

An Extension of the Anchor-Based MID Credibility Assessment Instrument Addressing Construct Proximity is a Reliable Alternative to the Correlation ItemPreprint

Wang, Y., Devji, T., Carrasco‐Labra, A., Qasim, A., Hao, Q., Kum, E., Devasenapathy, N., King, M. T., Terluin, B., Terwee, C. B., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4186779

Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata

Law, E. H., Williams, N., Korver, D., Bender, R. H., Mitra, D., Schaefer, G., & Nelson, L. M. (2024) · JEADV Clinical Practice · doi:10.1002/jvc2.441

Establishing minimal clinically important difference of modified dynamic gait index in people with subacute stroke

Mattos, F. G. M., Bowman, T., Longo, C. A., Bocini, S., Gennuso, M., Marazzini, F., Materazzi, F. G., Pelosin, E., Putzolu, M., Salvalaggio, S., et al. (2025) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2024.2437326

Additional file 1 of Development and evaluation of the Acromegaly Symptom Diary

Martin, S. A., Bender, R. H., Krasner, A. S., Marmon, T., Monahan, M., & Nelson, L. M. (2024) · Figshare · doi:10.6084/m9.figshare.26568934

Psychometric Evaluation of the Celiac Disease Symptom Diary 2.1 © Using Data from the Virtual Celiac Symptoms Study

ghura, S., Adams, D. W., Geller, M. G., Leffler, D. A., Liu, E., McLeod, L., Meckley, L. M., Tahir, M. J., Saad, R., & Rockwood, N. (2026) · Patient Related Outcome Measures · doi:10.2147/prom.s553006

Psychometric Evaluation of the Hypoparathyroidism Symptom Diary: Data from a Prospective Phase 3b/4 Study

Wang, S., Rockwood, N., Yarr, S., Korver, D., Castriota, F., Martin, S. A., & Ayodele, O. A. (2026) · Patient Related Outcome Measures · doi:10.2147/prom.s539994

Defining a Clinically Meaningful Within-Person Change Threshold for the Psychomotor Vigilance Test in Narcolepsy Type 1

Harel, B. T., Pietrzak, R. H., Dave, S., Maruff, P. T., Romero, H., Brimmer, M., & Doll, H. (2026) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-026-01025-8

Minimal Clinically Important Difference on the Social Responsiveness Scale in Autistic Children Aged 4 to 10 Years

Tan, H., Zhang, L., Xie, Z., Chen, L., Xu, W., Zhou, W., Ren, T., & Li, F. R. (2026) · Autism · doi:10.1177/13623613261481552

Measuring Hunger Severity in Rare MC4R Pathway Diseases: Development and Psychometric Evaluation of the Most Hunger Item

Clément, K., Roth, C. L., Kühnen, P., Haqq, A. M., Mallya, U. G., Ervin, C. M., Norcross, L., Bhargava, S., Argente, J., & Miller, J. L. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03741-x

Minimally important difference estimates and methods: a protocol

Johnston, B. C., Ebrahim, S., Carrasco‐Labra, A., Furukawa, T. A., Patrick, D. L., Crawford, M. W., Hemmelgarn, B. R., Schünemann, H. J., Guyatt, G. H., & NESRALLAH, G. E. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007953 · Cited by 148 · see citing works

Drop the “M”: Minimally Important Difference and Change Are Not Independent Properties of an Instrument and Cannot Be Determined as a Single Value Using Statistical Methods

Vickers, A. J., Nolla, K. M., & Cella, D. F. (2025) · Value in Health · doi:10.1016/j.jval.2024.09.018 · Cited by 7 · see citing works

Toward a rigorous assessment of the statistical performances of methods to estimate the Minimal Important Difference of Patient-Reported Outcomes: A protocol for a large-scale simulation study

Vanier, A., Leroy, M., & Hardouin, J.-B. (2022) · Methods · doi:10.1016/j.ymeth.2022.02.006 · Cited by 7 · see citing works

Minimally Important Difference: Empirical Comparison Of Estimation Methods Using Orthopaedics And Otolaryngology

Peterson, A., Sutherland, J. M., Crump, R., Liu, G., Janjua, A. S., Wing, K., Penner, M., & Younger, A. S. E. (2017) · Value in Health · doi:10.1016/j.jval.2017.08.1726

A point of minimal important difference (MID): a critique of terminology and methods

King, M. T. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.9 · Cited by 653 · see citing works